News

Merck Collaborates With Isomorphic Labs On AI Drug Discovery

NASDAQ

(RTTNews) - Thursday, Merck & Co., Inc. (MRK) announced a research collaboration with Isomorphic Labs, an AI-first drug design and development company, to discover therapeutic small molecule candidates against an oncology target of strategic importance.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.